AbCellera Biologics Inc. (ABCL) vs ICU Medical, Inc. (ICUI)

A side-by-side comparison of AbCellera Biologics Inc. and ICU Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ABCL vs ICUI

growth of $100 · dividends reinvested · last 6y
ABCL -76.6% (-21.5%/yr)ICUI -15.4% (-2.7%/yr)ICUI compounded faster over this window
050100Start $100202120222023202420252026$23$85
ABCL ICUI

ABCL vs ICUI: by the numbers

  • •ABCL is the larger company ($4.21B vs $4.00B market cap).
  • •ICUI is profitable (1.39% net margin) while ABCL runs a net loss (-248.83%).
  • •ICUI grew revenue faster over the past five years (11.05% vs -31.78% CAGR).

Metrics side by side

Valuation

MetricABCLICUI
P/E ratioN/A135.64
P/S ratio63.641.85
P/B ratio4.701.86
EV / EBITDAN/A13.68
FCF yieldN/A3.82%

Profitability

MetricABCLICUI
Gross margin61.64%37.56%
Operating margin-288.98%5.04%
Net margin-248.83%1.39%
ROE-18.38%1.40%
ROIC-17.95%3.11%

Growth (annualized)

MetricABCLICUI
Revenue CAGR (5Y)-31.78%11.05%
EPS CAGR (5Y)N/A-62.79%
FCF CAGR (5Y)N/A-2.65%
Total return CAGR (5Y)-3.57%-7.18%

Frequently asked

Which has grown faster, ABCL or ICUI?
Over the past five years, ICUI grew revenue faster — ABCL at a -31.78% CAGR versus ICUI at 11.05%.
Is ABCL or ICUI more profitable?
ICUI runs the higher net margin — ABCL at -248.83% versus ICUI at 1.39%.
How have ABCL and ICUI total returns compared?
Over the past 5 years, ABCL delivered -3.57% and ICUI delivered -7.18% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.